| The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 6373 | 2018 |
| The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Hepatology 55 (6), 2005-2023, 2012 | 5006 | 2012 |
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Gastroenterology 142 (7), 1592-1609, 2012 | 2094 | 2012 |
| Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States MR Charlton, JM Burns, RA Pedersen, KD Watt, JK Heimbach, ... Gastroenterology 141 (4), 1249-1253, 2011 | 1328 | 2011 |
| Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis MP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ... New England Journal of Medicine 373 (27), 2618-2628, 2015 | 955 | 2015 |
| Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ... Gastroenterology 149 (3), 649-659, 2015 | 950 | 2015 |
| Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 830 | 2015 |
| Evolution of causes and risk factors for mortality post‐liver transplant: results of the NIDDK long‐term follow‐up study KDS Watt, RA Pedersen, WK Kremers, JK Heimbach, MR Charlton American journal of transplantation 10 (6), 1420-1427, 2010 | 820 | 2010 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 708 | 2014 |
| Predictors of patient and graft survival following liver transplantation for hepatitis C M Charlton, E Seaberg, R Wiesner, J Everhart, R Zetterman, J Lake, ... Hepatology 28 (3), 823-830, 1998 | 614 | 1998 |
| Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the … D Goldberg, IC Ditah, K Saeian, M Lalehzari, A Aronsohn, EC Gorospe, ... Gastroenterology 152 (5), 1090-1099. e1, 2017 | 606 | 2017 |
| The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial R Loomba, E Lawitz, PS Mantry, S Jayakumar, SH Caldwell, H Arnold, ... Hepatology 67 (2), 549-559, 2018 | 564 | 2018 |
| Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C RH Wiesner, M Sorrell, F Villamil Liver Transplantation 9 (11), S1-S9, 2003 | 503 | 2003 |
| Nonalcoholic fatty liver disease: a review of current understanding and future impact M Charlton Clinical gastroenterology and hepatology 2 (12), 1048-1058, 2004 | 459 | 2004 |
| Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition M Charlton, A Krishnan, K Viker, S Sanderson, S Cazanave, A McConico, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 301 (5 …, 2011 | 456 | 2011 |
| Apolipoprotein synthesis in nonalcoholic steatohepatitis M Charlton, R Sreekumar, D Rasmussen, K Lindor, KS Nair Hepatology 35 (4), 898-904, 2002 | 452 | 2002 |
| Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes P Hirsova, SH Ibrahim, A Krishnan, VK Verma, SF Bronk, NW Werneburg, ... Gastroenterology 150 (4), 956-967, 2016 | 449 | 2016 |
| Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis ZM Younossi, R Loomba, QM Anstee, ME Rinella, E Bugianesi, ... Hepatology 68 (1), 349-360, 2018 | 412 | 2018 |
| A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation JS Crippin, T McCashland, N Terrault, P Sheiner, MR Charlton Liver Transplantation 8 (4), 350-355, 2002 | 410 | 2002 |
| Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation M Charlton, E Gane, MP Manns, RS Brown Jr, MP Curry, PY Kwo, ... Gastroenterology 148 (1), 108-117, 2015 | 408 | 2015 |
